首页 - 基金 - 交银医药创新股票C(014046) - 资产配置
交银医药创新股票C(014046)资产配置
序号 报告期 股票占净比(%) 债券占净比(%) 现金占净比(%) 净资产(元)
1 2026-06-30 85.19 - 14.98 1,719,352,302.25
2 2026-03-31 89.55 - 8.17 1,804,660,902.38
3 2025-12-31 91.13 - 12.52 1,967,429,453.78
4 2025-09-30 88.65 - 11.61 2,729,758,968.10
5 2025-06-30 84.46 - 16.26 2,594,784,909.34
6 2025-03-31 80.98 - 16.83 2,143,448,407.29
7 2024-12-31 84.23 - 16.24 2,203,044,691.50
8 2024-09-30 83.79 - 17.82 2,794,556,628.19
9 2024-06-30 82.87 - 17.15 2,785,259,887.37
10 2024-03-31 87.16 0.08 12.45 3,274,328,061.61
11 2023-12-31 88.56 - 12.18 3,875,492,914.77
12 2023-09-30 87.85 - 11.54 3,625,578,833.76
13 2023-06-30 85.96 - 13.61 3,729,838,599.02
14 2023-03-31 86.10 - 13.42 4,167,554,301.89
15 2022-12-31 87.57 - 12.76 3,690,270,171.46
16 2022-09-30 80.28 - 19.51 3,369,447,321.32
17 2022-06-30 83.55 - 17.45 4,204,050,427.36
18 2022-03-31 83.62 - 15.76 3,159,792,511.55
19 2021-12-31 88.18 0.01 11.98 3,915,923,734.61
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-